|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0400 USD | 0.00% |
|
+26.98% | +53.85% |
| 05-19 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | 0.00% | +26.98% | +166.67% | +100.00% | +53.85% | -84.19% | -96.15% | -98.99% | -99.56% | 10.6M | |
| +0.33% | -0.36% | -6.13% | -16.77% | -20.98% | +19.66% | -21.92% | +13.39% | +72.95% | 62.05B | |
| +0.20% | -9.17% | +4.65% | +1.26% | +4.65% | +58.54% | +194.67% | +193.14% | +286.35% | 54.52B | |
| -3.92% | +37.40% | +37.40% | +37.40% | +37.40% | +37.40% | +37.40% | +37.40% | - | 41.55B | |
| +7.62% | +8.19% | +18.13% | -16.01% | -32.63% | -51.58% | -58.97% | -61.93% | +7.61% | 39.06B | |
| -1.05% | -1.73% | +4.68% | +8.33% | +11.70% | +54.74% | -33.09% | -49.39% | -17.19% | 29.02B | |
| +3.50% | +28.15% | +32.92% | +24.48% | +116.89% | +146.95% | -48.51% | -67.89% | - | 25.38B | |
| -0.78% | -9.50% | +1.17% | +8.20% | -0.56% | +43.47% | +59.06% | +16.98% | +25.14% | 19.62B | |
| +1.74% | -0.39% | -4.09% | -6.05% | -0.13% | -1.99% | +126.64% | -12.02% | - | 16.89B | |
| -0.05% | +0.23% | +0.87% | +22.48% | +32.27% | +61.48% | +104.74% | +188.56% | +320.84% | 15.89B | |
| -1.66% | -0.79% | -2.86% | -3.31% | -13.36% | +58.81% | +301.15% | +8.05% | - | 12.98B | |
| -0.66% | -1.83% | +8.62% | +59.64% | +37.16% | +148.78% | +190.94% | +271.94% | +3,959.97% | 12.89B | |
| -4.33% | +4.90% | -1.67% | 0.00% | -21.36% | -9.36% | +703.41% | +439.69% | +6,047.83% | 12.37B | |
| -0.60% | -2.25% | +8.94% | +1.03% | -7.98% | -0.56% | -42.56% | -33.22% | -34.94% | 10.57B | |
| +1.87% | +9.46% | +15.23% | +38.29% | +41.18% | +162.77% | +178.96% | +433.02% | - | 10.26B | |
| +1.04% | +0.75% | -4.83% | +3.93% | -14.93% | -11.89% | -21.87% | -61.82% | -51.89% | 6.38B | |
| +5.66% | +14.95% | +63.18% | +108.13% | +176.04% | +152.77% | +380.04% | -21.29% | - | 5.45B | |
| -0.24% | -3.32% | -25.27% | -28.97% | -36.49% | -54.00% | -57.71% | -77.10% | - | 5.33B | |
| +3.53% | +2.44% | -8.29% | -16.87% | -2.27% | +8.19% | +240.25% | +179.22% | - | 5.32B | |
| +1.06% | -2.05% | -15.82% | -26.56% | -32.88% | -21.97% | +121.12% | +47.55% | +113.27% | 5.18B | |
| Average | +0.66% | +3.97% | +14.67% | +14.93% | +16.38% | +35.90% | +112.88% | +67.27% | +885.87% | 19.54B | |
| Weighted average by Cap. | +0.58% | +1.71% | +8.79% | +6.65% | +9.99% | +40.16% | +80.00% | +61.13% | +565.35% |
- Stock Market
- Stocks
- ADAPY Stock
- Sector Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
